Coagulation in liver toxicity and disease: Role of hepatocyte tissue factor

被引:28
|
作者
Kopec, Anna K. [1 ]
Luyendyk, James P. [1 ]
机构
[1] Michigan State Univ, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA
基金
美国国家卫生研究院;
关键词
Tissue factor; Hepatocyte; Liver disease; Coagulation; MICE; HEMOSTASIS; INJURY; CELL; CONTRIBUTES; THROMBOSIS; HYPERCOAGULATION; HEPATOTOXICITY; EXPRESSION; FIBROSIS;
D O I
10.1016/j.thromres.2014.03.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The liver is the primary source of a number of circulating coagulation factors, and acute liver injury and chronic liver disease are each associated with alterations in blood coagulation. Current views of the connection between liver injury and coagulation extend beyond the impact of liver disease on synthesis of coagulation factors to include a role for coagulation factor activity in the initiation and progression of liver disease. Mechanisms of coagulation initiation in liver disease are not completely understood. Compared to other tissues, liver expresses very low levels of tissue factor (TF). Recent studies indicate that expression of TF by hepatocytes comprises the majority of liver procoagulant activity, and that hepatocyte TF activates coagulation induced by liver injury. This review will briefly cover the expression and regulation of TF by hepatocytes, the role of TF in coagulation triggered by liver toxicity, and the contribution of coagulation activity to the progression of liver disease. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S57 / S59
页数:3
相关论文
共 50 条
  • [21] Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer
    Kotulkar, Manasi
    Paine-Cabrera, Diego
    Apte, Udayan
    SEMINARS IN LIVER DISEASE, 2024, 44 (03) : 383 - 393
  • [22] The role of hepatocyte nuclear factor 1β in disease and development
    El-Khairi, R.
    Vallier, L.
    DIABETES OBESITY & METABOLISM, 2016, 18 : 23 - 32
  • [23] Investigation for role of tissue factor and blood coagulation system in severe acute pancreatitis and associated liver injury
    Ou, Zhi-Bing
    Miao, Chun-Mu
    Ye, Ming-Xin
    Xing, Ding-Pei
    He, Kun
    Li, Pei-Zhi
    Zhu, Rong-Tao
    Gong, Jian-Ping
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 85 : 380 - 388
  • [24] Coagulation disorders and the role of tissue factor and tissue factor pathway inhibitor in critically ill patients
    F Frantzeskaki
    E Merkouri
    A Gialeraki
    E Paramythiotou
    M Theodorakopoulou
    O Travlou
    A Armaganidis
    I Dimopoulou
    Intensive Care Medicine Experimental, 3 (Suppl 1)
  • [25] Role of tissue factor pathway inhibitor in the regulation of tissue factor-dependent blood coagulation
    Golino, P
    Ragni, M
    Cimmino, G
    Forte, L
    CARDIOVASCULAR DRUG REVIEWS, 2002, 20 (01): : 67 - 80
  • [26] Direct Activation of Tissue Factor Procoagulant Activity By Bile Acids Drives Intrahepatic Coagulation in Liver Disease
    Baker, Kevin
    Kopec, Anna K.
    Iykovich, Dora
    Cline-Fedewa, Holly M.
    Olyaee, Mojtaba S.
    Woolbright, Benjamin L.
    Jaeschke, Hartmut
    Wolberg, Alisa S.
    Luyendyk, James P.
    HEPATOLOGY, 2018, 68 : 1350A - 1351A
  • [27] THE ROLE OF TISSUE FACTOR IN ACTIVATION COAGULATION SYSTEM AT PREGNANCY COMPLICATIONS
    Prochazka, M.
    Slavik, L.
    Prochazkova, J.
    Ulehlova, J.
    Novak, M.
    Polak, P.
    Pilka, R.
    THROMBOSIS RESEARCH, 2014, 133 : S109 - S109
  • [28] Coagulation factors and tumor cell biology: The role of tissue factor
    Donati, MB
    Lorenzet, R
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 : 22 - 25
  • [29] THE ROLE OF FACTOR-IX IN TISSUE THROMBOPLASTIN INDUCED COAGULATION
    VANDENBESSELAAR, AMHP
    RAM, IE
    ALDERKAMP, GHJ
    BERTINA, RM
    THROMBOSIS AND HAEMOSTASIS, 1982, 48 (01) : 54 - 58